dapagliflozin
astrazeneca
['dapagliflozin']
for any range of nt-probnp, there is absolute &amp; relative risk of hf across bmi, w/most clinically meaningful risk diff in those with low-level nt-probnp elevation (125-&lt;450). in this group, pattern of arr w/ #dapagliflozin for obese high risk pts. #acc23 
Providing the latest news and research from the TIMI Study Group, an ARO affiliated with Brigham and Women’s Hospital and Harvard Medical School.